Cannabis Market Surge: New York Hits 1.8 Billion While Federal Rescheduling Stalls

In the past 48 hours, the U.S. cannabis industry demonstrates steady state-level growth amid federal rescheduling delays and market consolidation, with New York's legal market surging to nearly 1.8 billion dollars in 2025 sales, up 73.8 percent year-over-year.[1][4] Ohio reports robust 2026 figures as of April 11, with 331.8 million dollars in combined medical and adult-use sales, including 282.5 million in recreational, across 40.9 million lifetime transactions; average flower prices dipped slightly to 6.45 dollars per gram from 6.61 a year ago, signaling easing supply pressures.[2] Regulatory momentum builds at the state level: Vermont lawmakers debated expanding its market on April 21,[5] Massachusetts doubled possession limits and reformed licensing,[6] and Delaware greenlit hospital use for terminally ill patients.[6] Federally, Congress pushes for a study on state laws to curb diversion.[6] Iowa's Democratic gubernatorial candidate Rob Sand proposed adult-use legalization on 4/20.[8] No major deals, partnerships, or product launches surfaced in the last 48 hours, but infrastructure expands, like Ohio's 209 dispensaries and growing licenses.[2] A UC San Diego study highlighted risks, linking teen cannabis use to slower brain development, potentially shifting youth consumer behavior.[3][7] Compared to prior reports, top markets like California and Michigan stagnated or dipped under 2.7 percent in 2025, while newcomers like Missouri (up 3.9 percent to 1.5 billion) and Ohio gain ground, with total top-15 sales exceeding 25 billion dollars last year.[4] Leaders respond via multistate operator investments in Maryland and New Jersey, poised to challenge veterans like Colorado.[4] Overall, demand holds firm despite headwinds, with projections for New York growth into 2026.[4] (Word count: 278) For great deals today, check out https://amzn.to/44ci4hQ This content was created in partnership and with the help of Artificial Intelligence AI.